Milpitas, CA – According to filings with the U.S. Securities and Exchange Commission, Bigfoot Biomedical is raising $55,128,488.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jeffrey Brewer played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Bigfoot Biomedical

Bigfoot Biomedical is a new kind of medical device company developing technologies to significantly reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. With an intense focus on ease of use, Bigfoot will optimize the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. The company’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model.

To learn more about Bigfoot Biomedical, visit http://www.bigfootbiomedical.com/

Contact:
Jeffrey Brewer, Chief Executive Officer
408-716-5600
jbrewer@bigfootbiomedical.com
https://www.linkedin.com/in/brewerjeffrey/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved